Adong Shen

1.1k total citations
51 papers, 732 citations indexed

About

Adong Shen is a scholar working on Epidemiology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Adong Shen has authored 51 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 12 papers in Pharmacology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Adong Shen's work include Pneumonia and Respiratory Infections (24 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Neonatal and Maternal Infections (9 papers). Adong Shen is often cited by papers focused on Pneumonia and Respiratory Infections (24 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Neonatal and Maternal Infections (9 papers). Adong Shen collaborates with scholars based in China, Russia and France. Adong Shen's co-authors include Weiwei Jiao, Lin Sun, Yonghong Yang, Kaihu Yao, Sangjie Yu, Yacui Wang, Wei Gao, Lin Zhou, Wei Zhao and Hui Qi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Adong Shen

50 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adong Shen China 18 394 170 140 132 129 51 732
Shigeto Hamaguchi Japan 15 294 0.7× 148 0.9× 169 1.2× 93 0.7× 105 0.8× 56 746
Tongchuan Li United States 12 265 0.7× 289 1.7× 541 3.9× 98 0.7× 98 0.8× 16 1.0k
Ganapathi I. Parameswaran United States 12 436 1.1× 132 0.8× 121 0.9× 66 0.5× 181 1.4× 19 918
Matthew Sims United States 15 204 0.5× 137 0.8× 197 1.4× 30 0.2× 29 0.2× 42 662
G. Paul Voorn Netherlands 15 471 1.2× 97 0.6× 204 1.5× 113 0.9× 70 0.5× 32 910
Andrea Hahn United States 16 225 0.6× 135 0.8× 304 2.2× 50 0.4× 16 0.1× 56 815
Giuseppe Magistro Germany 19 212 0.5× 281 1.7× 78 0.6× 29 0.2× 30 0.2× 83 1.2k
Jo Ellen Schweinle United States 11 572 1.5× 153 0.9× 179 1.3× 65 0.5× 46 0.4× 22 1.2k
Norihito Kaku Japan 15 196 0.5× 154 0.9× 186 1.3× 41 0.3× 29 0.2× 64 660
Waheed N. Khan United States 16 472 1.2× 43 0.3× 92 0.7× 97 0.7× 451 3.5× 32 902

Countries citing papers authored by Adong Shen

Since Specialization
Citations

This map shows the geographic impact of Adong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adong Shen more than expected).

Fields of papers citing papers by Adong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adong Shen. The network helps show where Adong Shen may publish in the future.

Co-authorship network of co-authors of Adong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Adong Shen. A scholar is included among the top collaborators of Adong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adong Shen. Adong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yue‐E, Bo‐Hao Tang, Guo‐Xiang Hao, et al.. (2022). Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis. Children. 9(12). 1998–1998. 5 indexed citations
2.
Wang, Zeming, Jing Bi, Yu Tang, et al.. (2022). Improving the efficacy for meropenem therapy requires a high probability of target attainment in critically ill infants and children. Frontiers in Pharmacology. 13. 961863–961863. 2 indexed citations
3.
4.
Tian, Xue, Lei Dong, Tingting Jiang, et al.. (2022). Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial. Frontiers in Pharmacology. 13. 1021661–1021661. 1 indexed citations
5.
Li, Fei-Na, Li Tuo, Shaowei Liu, et al.. (2021). Schumannella soli sp. nov., a novel actinomycete isolated from mangrove soil by in situ cultivation. Antonie van Leeuwenhoek. 114(10). 1657–1667. 4 indexed citations
6.
Wang, Zeming, Xiaoyu Chen, Jing Bi, et al.. (2020). Reappraisal of the Optimal Dose of Meropenem in Critically Ill Infants and Children: a Developmental Pharmacokinetic-Pharmacodynamic Analysis. Antimicrobial Agents and Chemotherapy. 64(8). 22 indexed citations
7.
Wu, Ping, et al.. (2020). The economic burden of medical treatment of children with asthma in China. BMC Pediatrics. 20(1). 386–386. 14 indexed citations
8.
Khan, Muhammad Wasim, Yakun Wang, Yue‐E Wu, et al.. (2020). Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia. European Journal of Clinical Pharmacology. 76(11). 1547–1556. 8 indexed citations
9.
Wang, Kai, Ronghua Wang, Yue‐E Wu, et al.. (2020). Developmental population pharmacokinetics–pharmacodynamics and dosing optimization of cefoperazone in children. Journal of Antimicrobial Chemotherapy. 75(7). 1917–1924. 7 indexed citations
10.
11.
Tang, Bo‐Hao, Yue‐E Wu, Hui Qi, et al.. (2018). Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants. Antimicrobial Agents and Chemotherapy. 63(2). 33 indexed citations
12.
Zheng, Yi, Shuping Liu, Baoping Xu, et al.. (2018). Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 62(9). 17 indexed citations
13.
Liu, Shuping, Yi Zheng, Xirong Wu, et al.. (2018). Early target attainment of azithromycin therapy in children with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 73(10). 2846–2850. 6 indexed citations
14.
Dong, Qian, et al.. (2018). A microscale HPLC‐UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates. Biomedical Chromatography. 32(8). e4243–e4243. 5 indexed citations
15.
Liu, Fang, Anxia Jiao, Xirong Wu, et al.. (2014). Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug–Induced Hepatotoxicity in Chinese Pediatric Patients. PLoS ONE. 9(12). e115410–e115410. 15 indexed citations
16.
Sun, Lei, Longfei Cheng, Binbin Wang, et al.. (2012). Novel Mutations of NODAL Gene in Chinese Patients with Congenital Heart Disease. Genetic Testing and Molecular Biomarkers. 16(4). 306–309. 1 indexed citations
17.
Zhou, Lin, Sangjie Yu, Wei Gao, et al.. (2011). Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010. Vaccine. 29(44). 7704–7710. 38 indexed citations
18.
Zhang, Weimin, et al.. (2009). Screening NXK2.5 Mutation in a Sample of 230 Han Chinese Children with Congenital Heart Diseases. Genetic Testing and Molecular Biomarkers. 13(2). 159–162. 24 indexed citations
19.
Xiao, Jing, Lin Sun, Weiwei Jiao, et al.. (2008). Lack of association between polymorphisms in the P2X7gene and tuberculosis in a Chinese Han population. FEMS Immunology & Medical Microbiology. 55(1). 107–111. 30 indexed citations
20.
Yang, Y., et al.. (1997). Group B Streptococcal Infections in Neonates and its Carriage in Women. Advances in experimental medicine and biology. 418. 251–253. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeto Hamaguchi Breakdown of academic impact, for papers by Tongchuan Li Breakdown of academic impact, for papers by Ganapathi I. Parameswaran Breakdown of academic impact, for papers by Matthew Sims Breakdown of academic impact, for papers by G. Paul Voorn Breakdown of academic impact, for papers by Andrea Hahn Breakdown of academic impact, for papers by Giuseppe Magistro Breakdown of academic impact, for papers by Jo Ellen Schweinle Breakdown of academic impact, for papers by Norihito Kaku Breakdown of academic impact, for papers by Waheed N. Khan
Rankless by CCL
2026